Atlas FDA

NOVOSTE(TM) BETA-CATH(TM) SYSTEM

FDA premarket approval P000018/S012 · decided 2001-08-01

Approval details

PMA number
P000018
Supplement
S012
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
NOVOSTE(TM) BETA-CATH(TM) SYSTEM
Generic name
Intravascular radiation delivery system
Applicant
Best Vascular, Inc.
Date received
2001-03-09
Decision date
2001-08-01
Days to decision
145 days
Decision code
APPR
Product code
MOU
Advisory committee
Cardiovascular
Expedited review
No
Location
Norcross, GA
Statement
APPROVAL FOR AN ALTERNATE METHOD OF RECEIPT AND ASSEMBLING OF SOURCE TRAINS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.